Statin Use and In-hospital Mortality in Patients with COVID-19 and Coronary Heart Disease

Lan Shen(Shanghai Chest Hospital), Ning Zhou(Tongji Hospital), Jingjin Jin(Tongji Hospital), Xiulan Liu(Tongji Hospital), Yi Liu(Wenzhou Medical University), Li Wang(Cleveland Clinic), Ying Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Dong Liu(Xinjiang Medical University), Ben He(Shanghai Jiao Tong University), Dao Wen Wang(Tongji Hospital), Lin Qiu(Ministry of Ecology and Environment), Hengye Huang(Shanghai Jiao Tong University)
Scientific Reports
December 13, 2021
10.1038/s41598-021-02534-2
Cited by 8

Related Papers

CircHIPK3 sponges miR‐558 to suppress heparanase expression in bladder cancer cells
|EMBO Reports|2017|596
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
SARS-CoV-2: a potential novel etiology of fulminant myocarditis
|Herz|2020|421
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273
Novel Chlorinated Polyfluorinated Ether Sulfonates and Legacy Per-/Polyfluoroalkyl Substances: Placental Transfer and Relationship with Serum Albumin and Glomerular Filtration Rate
|Environmental Science & Technology|2016|261